Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

10-Q

SEC Filing Details

Document Details

Form
Filing Date
May 14, 2013
Document Date
Mar 31, 2013
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved